
Pharmacally
Precision Medicine
Approvals, trial readouts, research and drug safety alerts, interpreted by pharmacists and checked against the primary source.
Latest in Precision Medicine
Mergers & AcquisitionsMcKesson to Acquire Precision Medicine Group for $2.25 Billion, Expanding Clinical Research and Biopharma ServicesMcKesson will acquire Precision Medicine Group for approximately $2.25 billion, expanding its clinical research, biomarker, laboratory, market access and biopharma commercialization capabilities within its Oncology & Multispecialty business.Fact-Checked
Mergers & AcquisitionsUCB Taps IMIDomics to Power Its Precision Medicine EngineUCB has acquired IMIDomics’ Patient Insights Business, securing access to a large, curated dataset and biobank to support precision medicine and accelerate development in immune-mediated diseases.Fact-Checked
Explore more
Health TidingsIndustry, pipeline and company news.
RegulatoryApprovals, policy and agency decisions.
ResearchPeer-reviewed studies and scientific breakthroughs.
Drug FinderLook up any drug: uses, dosing and safety.
From the HistoryLandmark moments in pharmaceutical history.
LatestEvery new story, as soon as it is published.